Considerations for the design of vaccine efficacy trials during public health emergencies (2018)
Attributed to:
MRC Centre for Global Infectious Disease Analysis
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1101/261875
Publication URI: http://dx.doi.org/10.1101/261875
Type: Preprint